Skip to content

Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation

The Effects of GM-CSF, HB-EGF and LIF Cytokines Supplementation Need Verification for Human Embryo Development in Vitro

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02420886
Acronym
GHLCSHED
Enrollment
443
Registered
2015-04-20
Start date
2015-05-16
Completion date
2016-03-31
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

In Vitro culture of human embryos

Brief summary

Assessment of the embryological benefit of in vitro adding of Cytokines (LIF 5ng/ml, HB-EGF 5ng/ml and GM-CSF 2n/ml) to the culture media and closely monitor its effect on embryogenesis and implantation outcomes.

Detailed description

The IVF culture media design and upgrade underwent many ideas during the last 3 decades, we suppose that adding the Cytokines (LIF 5ng/ml, HB-EGF 5ng/ml and GM-CSF 2ng/ml) as a growth factor that have multi-ways to might improve embryo development in vitro so we decide to design a trial to compare the embryogenesis by sibling Oocytes of the same patient between two arm of the same culture media and the same culture condition. One arm with Cytokines and the other is traditional one and closely monitor the outcome within the 2 arms and record the results.

Interventions

OTHERAdding LIF, HB-EGF and GM-CSF to Lifeglobal human IVF culture media

Sponsors

Banon IVF Center Assiut, Egypt
CollaboratorOTHER
Ibn Sina Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* all patients

Exclusion criteria

* over 40 years

Design outcomes

Primary

MeasureTime frame
ongoing pregnancy rate ( % )6 months

Secondary

MeasureTime frame
implantation rate6 months
fertilization rate6 days of culture
clinical pregnancy rate ( % )6 months
rates for blastocyst formation and quality6 days of culture
embryo utilization rate6 days of culture
top-quality embryo rate6 days of culture

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026